BSECompany Update27 Aug 2026 · 27 Aug 2026, 05:22 pm
Investors Meet
Cohance Lifesciences Ltd · 543064
✦ AI SummaryMgmt Change
Cohance Lifesciences Ltd has announced an investors meet on 1 September 2026 at Ashwamedh - Elara India Dialogue 2026 in Mumbai, where the company's management will be present for group and one-on-one interactions. The schedule is subject to change and no unpublished price-sensitive information will be shared.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
f48ba4e4-7f71-4b81-89d5-aa684f8afa05.pdf
View document text
27 August 2026
To To
BSE Limited National Stock Exchange of India Limited
25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051
Code: 543064 Symbol: COHANCE
Dear Sir/Madam,
Sub: Intimation regarding Analysts/ Institutional Investors Meet
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
please note that the management of the Company will be attending the below mentioned Conference:
Date Conference Location Group/One-one
1 September 2026 Ashwamedh - Elara India Dialogue 2026 Mumbai Group and One-on-One
Note:
The schedule of the aforesaid meets is subject to change. The change may happen due to exigencies on the
part of Analyst/ Institutional Investor/ Company.
No unpublished price-sensitive information will be shared during this interaction.
Kindly take the above on record.
Thanking you.
Yours faithfully,
For Cohance Lifesciences Limited
(formerly, Suven Pharmaceuticals Limited)
Sisir K. Mishra
Company Secretary & Compliance Officer